Logo image of PED

PEDEVCO CORP (PED) Stock Fundamental Analysis

NYSEARCA:PED - NYSE Arca - US70532Y3036 - Common Stock - Currency: USD

0.65  0 (-0.51%)

After market: 0.6709 +0.02 (+3.22%)

Fundamental Rating

5

Taking everything into account, PED scores 5 out of 10 in our fundamental rating. PED was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. PED has only an average score on both its financial health and profitability. PED has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PED was profitable.
PED had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PED reported negative net income in multiple years.
Each year in the past 5 years PED had a positive operating cash flow.
PED Yearly Net Income VS EBIT VS OCF VS FCFPED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of PED (11.78%) is better than 86.85% of its industry peers.
With a decent Return On Equity value of 14.10%, PED is doing good in the industry, outperforming 69.01% of the companies in the same industry.
PED has a worse Return On Invested Capital (2.81%) than 68.54% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PED is significantly below the industry average of 23.55%.
Industry RankSector Rank
ROA 11.78%
ROE 14.1%
ROIC 2.81%
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
PED Yearly ROA, ROE, ROICPED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

The Profit Margin of PED (42.71%) is better than 91.08% of its industry peers.
Looking at the Operating Margin, with a value of 11.38%, PED is doing worse than 60.09% of the companies in the same industry.
PED's Gross Margin of 66.82% is fine compared to the rest of the industry. PED outperforms 75.59% of its industry peers.
In the last couple of years the Gross Margin of PED has grown nicely.
Industry RankSector Rank
OM 11.38%
PM (TTM) 42.71%
GM 66.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
PED Yearly Profit, Operating, Gross MarginsPED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PED is destroying value.
The number of shares outstanding for PED has been increased compared to 1 year ago.
PED has more shares outstanding than it did 5 years ago.
PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PED Yearly Shares OutstandingPED Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PED Yearly Total Debt VS Total AssetsPED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PED has an Altman-Z score of 0.91. This is a bad value and indicates that PED is not financially healthy and even has some risk of bankruptcy.
PED has a Altman-Z score of 0.91. This is comparable to the rest of the industry: PED outperforms 42.25% of its industry peers.
There is no outstanding debt for PED. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACC0.3
WACC9.38%
PED Yearly LT Debt VS Equity VS FCFPED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.40 indicates that PED should not have too much problems paying its short term obligations.
The Current ratio of PED (1.40) is better than 64.32% of its industry peers.
A Quick Ratio of 1.40 indicates that PED should not have too much problems paying its short term obligations.
PED's Quick ratio of 1.40 is fine compared to the rest of the industry. PED outperforms 69.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
PED Yearly Current Assets VS Current LiabilitesPED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 223.33% over the past year.
Looking at the last year, PED shows a very strong growth in Revenue. The Revenue has grown by 30.69%.
Measured over the past years, PED shows a very strong growth in Revenue. The Revenue has been growing by 24.98% on average per year.
EPS 1Y (TTM)223.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)30.69%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%7.64%

3.2 Future

Based on estimates for the next years, PED will show a very negative growth in Earnings Per Share. The EPS will decrease by -36.44% on average per year.
The Revenue is expected to decrease by -0.26% on average over the next years.
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.14%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PED Yearly Revenue VS EstimatesPED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
PED Yearly EPS VS EstimatesPED Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.42, the valuation of PED can be described as very cheap.
96.71% of the companies in the same industry are more expensive than PED, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.59, PED is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.04, the valuation of PED can be described as reasonable.
76.06% of the companies in the same industry are more expensive than PED, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PED to the average of the S&P500 Index (22.39), we can say PED is valued rather cheaply.
Industry RankSector Rank
PE 3.42
Fwd PE 8.04
PED Price Earnings VS Forward Price EarningsPED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PED is valued cheaply inside the industry as 92.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.39
PED Per share dataPED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as PED's earnings are expected to decrease with -36.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PED!.
Industry RankSector Rank
Dividend Yield N/A

PEDEVCO CORP

NYSEARCA:PED (6/10/2025, 8:04:00 PM)

After market: 0.6709 +0.02 (+3.22%)

0.65

0 (-0.51%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-12 2025-08-12
Inst Owners2.95%
Inst Owner Change-9.05%
Ins Owners73.01%
Ins Owner Change4.62%
Market Cap59.37M
Analysts80
Price Target1.86 (186.15%)
Short Float %0.43%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)602.98%
Min EPS beat(2)-73.6%
Max EPS beat(2)1279.56%
EPS beat(4)3
Avg EPS beat(4)330.55%
Min EPS beat(4)-73.6%
Max EPS beat(4)1279.56%
EPS beat(8)3
Avg EPS beat(8)146.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.87%
Min Revenue beat(2)-4.95%
Max Revenue beat(2)12.69%
Revenue beat(4)3
Avg Revenue beat(4)6.64%
Min Revenue beat(4)-4.95%
Max Revenue beat(4)17.66%
Revenue beat(8)6
Avg Revenue beat(8)7.09%
Revenue beat(12)7
Avg Revenue beat(12)4.43%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.39%
EPS NQ rev (1m)49.97%
EPS NQ rev (3m)400%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.15%
Valuation
Industry RankSector Rank
PE 3.42
Fwd PE 8.04
P/S 1.48
P/FCF N/A
P/OCF 2.58
P/B 0.49
P/tB 0.49
EV/EBITDA 2.39
EPS(TTM)0.19
EY29.23%
EPS(NY)0.08
Fwd EY12.43%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.25
OCFY38.72%
SpS0.44
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 14.1%
ROCE 3.55%
ROIC 2.81%
ROICexc 3.05%
ROICexgc 3.05%
OM 11.38%
PM (TTM) 42.71%
GM 66.82%
FCFM N/A
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
ROICexc(3y)3.72%
ROICexc(5y)N/A
ROICexgc(3y)3.72%
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 178.98%
Cap/Sales 70.92%
Interest Coverage 250
Cash Conversion 112.2%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z 0.91
F-Score7
WACC9.38%
ROIC/WACC0.3
Cap/Depr(3y)201.19%
Cap/Depr(5y)159.31%
Cap/Sales(3y)75.11%
Cap/Sales(5y)87.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)223.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.69%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%7.64%
Revenue Next Year-6.14%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.69%
OCF growth 3Y28.83%
OCF growth 5Y50.2%